360dx18h
Tempus Expects $600M Ambry Genetics Acquisition to Accelerate Path to Cash Flow Breakeven
The firm's Q3 2024 revenues rose 33 percent year over year as both its genomics and data and services revenues increased in the double-digit percent range.
360dx18h
Hologic Revenues Rise 5 Percent on Strength of Molecular Diagnostics Business
The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.
360dx23h
Owners of Lab, Marketing Firms Convicted of Multimillion Dollar Genetic Testing Fraud Scheme
Fadel Alshalabi, owner and CEO of Crestar Labs, and Samuel Harris, owner of Flojo Recruiting conspired to bill Medicare and Medicaid for millions of dollars in genetic test orders.
360dx19h
Digital Pathology Firm OptraScan Raises $30M in Series B Round
NEW YORK – Digital pathology company OptraScan announced on Tuesday that it has closed a $30 million Series B financing round. The round was led by molecular diagnostics firm Molbio Diagnostics. The ...
360dx19h
Antimicrobial Susceptibility Tech Firm iFast Diagnostics Raises $6.5M
NEW YORK — UK-based iFast Diagnostics said on Tuesday that it has raised $6.5 million in seed funding. The financing round was led by KHP Ventures and included EInk, Raw Ventures, and OKG Capital, as ...